Cargando…

Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study

BACKGROUND: Loop diuretics are recommended by clinical practice guidelines to treat volume overload in acute decompensated heart failure (ADHF). The effectiveness of switching furosemide to torsemide versus optimizing the furosemide dose following ADHF has not yet been evaluated. METHODS: This retro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahhal, Alaa, Saad, Mohamed Omar, Tawengi, Kawthar, Assi, Abed Al Raouf, Habra, Masa, Ahmed, Dalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540376/ https://www.ncbi.nlm.nih.gov/pubmed/31138146 http://dx.doi.org/10.1186/s12872-019-1112-5

Ejemplares similares

Proteomic differences among patients with heart failure taking furosemide or torsemide
por: Cooper, Lauren B., et al.
Publicado: (2022)

Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content
por: Ragab, Dalia, et al.
Publicado: (2018)

Evaluation of the short‐term echocardiographic effects of two loop diuretics, furosemide and torsemide, in a group of dogs
por: Hosseini, Farzaneh, et al.
Publicado: (2023)

Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective
por: Ahmed, Fozia Z., et al.
Publicado: (2021)

Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
por: de Grooth, Harm-Jan S, et al.
Publicado: (2014)

The Potential Role of Torsemide in Optimizing Loop Diuretic Therapy for Heart Failure Patients
por: Chopra, V. K, et al.
Publicado: (2023)

Women Hospitalized for Acute on Chronic Decompensated Systolic Heart Failure Receive Less Furosemide Compared to Men
por: Rasmussen, Tyler P., et al.
Publicado: (2019)

A case of bullous pemphigoid induced by torsemide
por: Wurtz, Paul, et al.
Publicado: (2022)

A Pharmacogenetic Investigation of Intravenous Furosemide in Decompensated Heart Failure: A Meta-Analysis of 3 Clinical Trials
por: de Denus, Simon, et al.
Publicado: (2016)

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
por: Ibrahim, Ayman, et al.
Publicado: (2020)

Pharmacokinetic and pharmacodynamic properties of orally administered torsemide in healthy horses
por: Agne, Gustavo F., et al.
Publicado: (2018)

Diabetes patient management by pharmacists during Ramadan
por: Wilbur, Kerry, et al.
Publicado: (2014)

The added value of hypertonic saline solution to furosemide monotherapy in patients with acute decompensated heart failure: A meta‐analysis and trial sequential analysis
por: Diaz‐Arocutipa, Carlos, et al.
Publicado: (2023)

‘Door-to-furosemide’ timing: early treatment of heart failure
por: Piazza, Vito
Publicado: (2019)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Decompensated heart failure
por: Mangini, Sandrigo, et al.
Publicado: (2013)

Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction
por: Zheng, Zhigui, et al.
Publicado: (2021)

Sodium and Fluid Excretion With Torsemide in Healthy Subjects is Limited by the Short Duration of Diuretic Action
por: Shah, Salim, et al.
Publicado: (2017)

Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
por: Frățilă, Georgiana, et al.
Publicado: (2023)

Addition of Tolvaptan Compared With Increased Dose of Furosemide in Heart Failure Patients With Chronic Kidney Disease Under Furosemide Treatment
por: Tanaka, Toshiki, et al.
Publicado: (2018)

Iatrogenic Decompensated Heart Failure
por: Tran, Patrick, et al.
Publicado: (2020)

A Life-Threatening Case of Torsemide-Induced Toxic Epidermal Necrolysis Associated With the Treatment of Anasarca
por: Reddy, Sujana, et al.
Publicado: (2022)

Long‐term Stability of a Compounded Suspension of Torsemide (5 mg/mL) for Oral Administration
por: Adin, D., et al.
Publicado: (2017)

Differences in the Biomarker Profile of De Novo Acute Heart Failure versus Decompensation of Chronic Heart Failure
por: Nawrocka-Millward, Sylwia, et al.
Publicado: (2021)

Acute Decompensated Heart Failure Update
por: Teerlink, John R, et al.
Publicado: (2015)

Multimodality imaging in decompensated heart failure
por: D’Andrea, Antonello, et al.
Publicado: (2023)

Evaluation of diuretic efficiency of intravenous furosemide in patients with advanced heart failure in a heart failure clinic
por: Herrera-Leaño, Nancy, et al.
Publicado: (2023)

Effects of furosemide and tadalafil in both conventional and nanoforms against adenine-induced chronic renal failure in rats
por: Hamdy, Moustafa Mahmoud, et al.
Publicado: (2022)

Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution
por: Sica, Domenic A., et al.
Publicado: (2018)

Association of early administration of furosemide with improved oxygenation in patients with acute heart failure
por: Mikami, Takafumi, et al.
Publicado: (2021)

A Simplified HPLC Method for Quantification of Torsemide from Human Plasma and its Application to a Bioequivalence Study
por: Khan, I. J., et al.
Publicado: (2008)

The Role of Ultrafiltration in Patients with Decompensated Heart Failure
por: Kamath, Sandeep A.
Publicado: (2010)

Management of Mechanical Ventilation in Decompensated Heart Failure
por: Kuhn, Brooks T., et al.
Publicado: (2016)

Impact of environmental factors on heart failure decompensations
por: Escolar, Vanessa, et al.
Publicado: (2019)

Iron Deficiency in Acute Decompensated Heart Failure
por: Beale, Anna, et al.
Publicado: (2019)

Hypoalbuminemia in Patients with Acute Decompensated Heart Failure
por: Imamura, Teruhiko
Publicado: (2019)

Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial
por: Balsam, Paweł, et al.
Publicado: (2020)

Comparison of Different Furosemide Regimens in the Treatment of Acute Heart Failure: A Meta-Analysis
por: Huang, Youpan, et al.
Publicado: (2022)

Pro‐Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction
por: Abernethy, Abraham, et al.
Publicado: (2018)

Sex differences in patients with acute decompensated heart failure in Japan: observation from the KCHF registry
por: Yamamoto, Erika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k0mntpq8t0hlv26bckolva0si0